Summary |
A pharmaceutical composition for inhibiting the expression of cytokines of T helper cell type II (Th2 cell) and/or inhibiting the expression of chemokines is provided, wherein the pharmaceutical composition comprises an effective amount of an active component, and the active component is selected from a group consisting of a compound of formula (I), pharmaceutically acceptable salts and esters of the compound, and combinations thereof: Also provided are uses of the compound of formula (I), and/or the pharmaceutically acceptable salts and/or esters thereof in the manufacture of a medicament. |
Scientific Breakthrough |
A pharmaceutical composition for inhibiting the expression of cytokines of T helper cell type II (Th2 cell) and/or inhibiting the expression of chemokines is provided, wherein the pharmaceutical composition comprises an effective amount of an active component, and the active component is selected from a group consisting of a compound of formula (I), pharmaceutically acceptable salts and esters of the compound, and combinations thereof: Also provided are uses of the compound of formula (I), and/or the pharmaceutically acceptable salts and/or esters thereof in the manufacture of a medicament. |